61 unknown. 61 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 61 | Unknown 61 |
Follow Behavioral Symptoms: new trials by email Literature Review of Behavioral Symptoms trials Research Report on Behavioral Symptoms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Dolutegravir Compared With Darunavir/Cobicistat on the Severity of Neuropsychiatric Effects al 12 Weeks in Antirretroviral Treatment-Naive Adults. Dolutegravir (DTG), Darunavir/Cobicistat (FDC) - HIV, Insomnia | Phase 4 | Unknown | Instituto Mexicano del Seguro Social | 140 | 2025-06-19 | 2025-06-26 |
| A Study of Mianserin in Combination With SSRIs in Depression With Sleep Problems Mianserin, Lorazepam - Depression | Phase 4 | Unknown | Zhenghui YI | 300 | 2024-07-01 | 2024-06-27 |
| The Effects of DPPIs on Cognitive Function of Diabetic Patients Control group, DPP-4 inhibitor group, DPP-4 inhibitor + metformin group - Cognitive Impairment | Phase 4 | Unknown | Beni-Suef University | 105 | 2023-12-30 | 2023-12-11 |
| Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder Dexmedetomidine, Lorazepam 2 MG/ML - Schizophrenia Agitation, Schizo Affective Disorder | Phase 4 | Unknown | Temple University | 32 | 2023-07-01 | 2023-10-23 |
| Prophylactic Effects of Agomelatine for Poststroke Depression Agomelatine, Placebo Tablets - Depression, Acute Ischemic Stroke | Phase 4 | Unknown | First Affiliated Hospital, Sun Yat-Sen University | 420 | 2022-10-01 | 2022-07-27 |
| Safety and Efficacy Evaluation of S (+) - Ketamine in Children Conventional therapy + S (+)-Ketamine, Conventional therapy - S-ketamine, Esketamine | Phase 4 | Unknown | Chinese PLA General Hospital | 3000 | 2022-04-20 | 2024-03-08 |
| Nalbuphine Versus Dexmedetomidine for Prevention of Emergence Agitation in Pediatrics Nalbuphine, Dexmedetomidine, normal Saline - Agitation | Phase 4 | Unknown | Alexandria University | 126 | 2022-03-01 | 2022-04-08 |
| Effect of Esketamine on Postoperative Depression、Gut Microbiota、Bispectral Index Data of Depression Patients Undergoing Breast Cancer Operation (ESPOD-BI) Esketamine, Saline Solution - Depression | Phase 4 | Unknown | China Medical University, China | 72 | 2021-10-08 | 2024-07-22 |
| Safety and Efficacy Evaluation of S (+) - Ketamine in Adults Conventional therapy + S (+)-Ketamine, Conventional therapy - Postoperative Pain, Adults | Phase 4 | Unknown | Chinese PLA General Hospital | 12000 | 2021-05-01 | 2021-04-08 |
| MBRP + Vortioxetine VS MBRP on Preventing Relapse in Chronic MA Users Vortioxetine - Relapse, Cognitive Impairment | Phase 4 | Unknown | Sir Run Run Shaw Hospital | 220 | 2020-09-01 | 2019-11-29 |
| Anti-inflmmation Treatment in Mood Disorder and Deep Learning Prediction Model Aspirin, Atorvastatin - Mood Disorder | Phase 4 | Unknown | Taipei Veterans General Hospital, Taiwan | 180 | 2020-08-24 | 2020-12-28 |
| Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal Enuresis Posterior tibial nerve stimulation, Desmopressin Acetate - Primary Monosymptomatic Nocturnal Enuresis | Phase 4 | Unknown | Cairo University | 80 | 2020-03-15 | 2020-09-11 |
| Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD) Escitalopram, Duloxetine - Anxious Depression, Depression | Phase 4 | Unknown | University of Cincinnati | 84 | 2020-03-01 | 2024-08-29 |
| Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A) Duloxetine, Escitalopram - Anxiety, Depressive Symptoms | Phase 4 | Unknown | University of Cincinnati | 60 | 2020-01-01 | 2024-08-29 |
| Accurate Clinical Study of Medication in Patients With Depression Via Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) of Venlafaxine pharmacogenomics, pharmacogenomics & therapeutic drug monitoring, Venlafaxine - Depression | Phase 4 | Unknown | Xijing Hospital | 160 | 2019-12-01 | 2019-12-20 |
| Tolerability, Safety and Efficacy of Vortioxetine Vortioxetine - Depression | Phase 4 | Unknown | IRCCS San Raffaele Roma | 20 | 2019-11-20 | 2023-06-22 |
| the Efficacy and Safety of Agomelatine in the Patients With Parkinson's Disease Agomelatine or PIacebo - Parkinson Disease, Depression | Phase 4 | Unknown | Second Affiliated Hospital of Soochow University | 240 | 2019-07-01 | 2019-06-06 |
| Influenza Vaccine as a Novel Experimental Model of the Behavioral Immune Response in Depression Influenza Vaccine - Depression, Healthy | Phase 4 | Unknown | University of Texas at Austin | 75 | 2019-06-10 | 2019-06-27 |
| Ketamine Co-induction for Patients With Major Depressive Disorder Ketamine Hydrochloride, Propofol, Fentanyl - Ketamine, Depression | Phase 4 | Unknown | University of Saskatchewan | 50 | 2018-12-01 | 2018-09-13 |
| MYnd Analytics Directed Therapy in Depression MYnd Analytics PEER Online directed antidepressant therapy, Conventional antidepressant therapy - Depression | Phase 4 | Unknown | Cota Inc. | 600 | 2017-10-01 | 2017-11-06 |
Showing 20 of 61. Sign in to see all of them.
Depression (48) · Depressive Disorder, Major (11) · Psychomotor Agitation (8) · Anxiety Disorders (4) · Aggression (3) · Bipolar Disorder (3) · Parkinson Disease (3) · Schizophrenia (3) · Acute Pain (2) · Attention Deficit Disorder with Hyperactivity (2) · Cognitive Dysfunction (2) · Delirium (2) · Depressive Disorder (2) · Hyperalgesia (2) · Mood Disorders (2)
Behavior (61) · Mental Disorders (32) · Nervous System Diseases (22) · Pathological Conditions, Signs and Symptoms (20) · Signs and Symptoms (17) · Neurologic Manifestations (15) · Mood Disorders (14) · Depressive Disorder (12) · Aberrant Motor Behavior in Dementia (11) · Neurobehavioral Manifestations (10) · Brain Diseases (8) · Central Nervous System Diseases (8) · Dyskinesias (8) · Psychomotor Disorders (8)
Escitalopram (10) · Dexmedetomidine (6) · Duloxetine Hydrochloride (6) · Ketamine (6) · Saline Solution (6) · Sertraline (5) · Venlafaxine Hydrochloride (4) · Citalopram (3) · Esketamine (3) · Paroxetine (3) · Vortioxetine (3) · Deamino Arginine Vasopressin (2) · Lorazepam (2) · Propofol (2) · Sodium Chloride (2)
Chinese PLA General Hospital (2) · Seoul National University Hospital (2) · Sheba Medical Center (2) · University of Cincinnati (2) · Ain Shams University (1) · Alexandria University (1) · Asan Medical Center (1) · BRC Operations Pty. Ltd. (1) · Baker Heart and Diabetes Institute (1) · Bayside Health (1) · Beijing Hospital (1) · Beijing Hospital of Traditional Chinese Medicine (1) · Beni-Suef University (1) · Bispebjerg Hospital (1) · Cairo University (1)
United States (11) · China (8) · Canada (6) · Egypt (4) · Israel (4) · South Korea (4) · Australia (3) · Denmark (2) · Germany (2) · Italy (2) · Brazil (1) · Finland (1) · France (1) · Japan (1) · Mexico (1)
Jayashri Kulkarni, Prof (2) · Weidong Mi, MD (2) · AhYoung Oh (1) · Alaa Elkateb, MD (1) · Anette Green Nielsen, Stud. pharm (1) · Angelo Sambunaris, MD (1) · Anna Sverdlik, MD (1) · Anthony Harris, MD (1) · Barbara A. Cohen, PhD (1) · Bruce Russell, PhD (1) · Chantal Csajka, Prof PhD (1) · Charles Debattista, MD (1) · Chun-Feng Liu, MD (1) · Claudio N Soares, MD, PhD (1) · Con Stough, PhD (1)
PMID 16247923, PMID 18052566, PMID 18583104, PMID 18673165, PMID 19341510, PMID 19351383, PMID 20441723, PMID 20616670, PMID 20975325, PMID 21170955, PMID 21208417, PMID 21569445, PMID 21959915, PMID 22562047, PMID 23422376, PMID 23866851, PMID 23941474, PMID 24290461, PMID 24679400, PMID 24690111, PMID 24970773, PMID 25326163, PMID 25815419, PMID 25815420, PMID 25824424, PMID 25917683, PMID 26137532, PMID 26282359, PMID 26360086, PMID 26745211, PMID 26995298, PMID 27137427, PMID 27791054, PMID 28012485, PMID 28237506, PMID 29030421, PMID 29133948, PMID 29355727, PMID 29886724, PMID 30311742, PMID 30710613, PMID 30944021, PMID 31023398, PMID 31341158, PMID 31477195, PMID 31513968, PMID 31601424, PMID 31695168, PMID 32007604, PMID 32023608
2018 (1), R01MH068391 (1)